Actio Biosciences Funding: $55M Raised, Series B (2025)
Actio Biosciences is a Biotech company based in San Diego, CA. It has raised $55M in total funding. Latest round: Series B.
Actio Biosciences funding overview
Actio Biosciences is a Biotech company based in San Diego, CA. Actio Biosciences has raised $55M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in June 2025. The round record for Actio Biosciences runs through 2025; nothing later has been disclosed. Investors on record include Regeneron Ventures, Deerfield Management. 2 distinct backers are named across the disclosed rounds.
Actio Biosciences at a glance
Total raised
$55M
Latest round
Series B
Latest round date
June 2025
Industry
Biotech
Headquarters
San Diego, CA
Notable investors
Regeneron Ventures, Deerfield Management
Frequently asked about Actio Biosciences funding
How much has Actio Biosciences raised?
Actio Biosciences has raised $55M in total disclosed funding across the rounds on record.
Who has invested in Actio Biosciences?
Regeneron Ventures, Deerfield Management are named among the investors backing Actio Biosciences.
What was the latest Actio Biosciences funding round?
The most recent disclosed round is a Series B, announced in June 2025.
Where is Actio Biosciences based?
Actio Biosciences is based in San Diego, CA.
What sector does Actio Biosciences operate in?
Actio Biosciences is tracked under Biotech from San Diego, CA, with $55M in disclosed funding.
When did Actio Biosciences last raise?
The last disclosed Actio Biosciences round closed in June 2025 at Series B.
We update the Actio Biosciences record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in San Diego and their backers are listed below.
